Ocular Therapeutix, Inc. (NASDAQ:OCUL) will hold its 2Q20 earnings conference call with the financial community on 7th August 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.ocutx.com
Earnings Expectation
Ocular Therapeutix, Inc. is set to announce second quarter earning results on Friday 7th August 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, OCUL to report 2Q20 loss of $ 0.31 per share. For the full year, analysts anticipate top line of $ 15.94 million, while looking forward to loss of $ 1.14 per share bottom line.
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, a hydrogel ophthalmic wound sealant to seal corneal incisions following cataract surgery. Its lead product candidate is DEXTENZA (dexamethasone ophthalmic insert) for the treatment of post-surgical ocular pain and inflammation, allergic conjunctivitis, and dry eye diseases.
